Study Informs About Risks of Discontinuing Meds in JIA : com

If patients with JIA flare after discontinuing therapy, the majority regain disease control when treatment is restarted, according to preliminary results from an ongoing study.

Related Keywords

Germany , Boston , Massachusetts , United States , Berlin , German , Olha Halyabar , Sarah Ringold , Jens Klotsche , Leibniz Institute , Rheumatology Research Alliance , German Rheumatism Research Center , Rheumatology Research Foundation , Rheumatology Research , Seattle Children , Childhood Arthritis , Global Assessment , Juvenile Arthritis Disease Activity Score , Boston Children , Juvenile Rheumatoid Arthritis , Rheumatoid Arthritis , A , Children , Child , Childhood , Ediatrics , Kids , Remission , Disease Modifying Antirheumatic Drugs Dmards , Mard Disease Modifying Antirheumatic Drug , Health Care Quality Access Evaluation , Rheumatic Disease , Social Determinants Of Health , Adverse Effects , Side Effects ,